Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Brainstorm Cell Therapeutics Inc
GHDNCurrent price
0.23 EUR
0 EUR (0.00%)
Last closed
0.23 EUR
Company
www.brainstorm-cell.com
ISIN
US10501E2019
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
20 296 469 EUR
Yield for 12 month
-74.61 %
1Y
3Y
5Y
10Y
15Y
GHDN
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Address: 1325 Avenue of Americas, New York, NY, United States, 10019
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
10.34 EURP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures GHDN
1 year
3 years
5 years
10 years
EBITDA
-16 035 232 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-178.2 %
PEG Ratio
–
Return On Equity TTM
-1121.9 %
Wall Street Target Price
10.34 EUR
Revenue TTM
–
Book Value
-0.044 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.2 EUR
Diluted Eps TTM
-0.2 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GHDN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GHDN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GHDN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.5912
Price Book MRQ
62.9149
Financials GHDN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GHDN
For 52 weeks
0.11 EUR
0.95 EUR
50 Day MA
0.29 EUR
Shares Short Prior Month
–
200 Day MA
0.35 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart